Kidney function in cyclosporine-treated paediatric pulmonary transplant recipients

被引:18
|
作者
Tsimaratos, M [1 ]
Viard, L
Kreitmann, B
Remediani, C
Picon, G
Camboulives, J
Sarles, J
Metras, D
机构
[1] Grp Hosp Timone, Hop Enfants, Serv Pediat Multidisciplinare, Dept Multidisciplinary Paediat, F-13385 Marseille 05, France
[2] Grp Hosp Timone, Hop Enfants, Dept Paediat Intens Care, F-13385 Marseille, France
[3] Grp Hosp Timone, Hop Enfants, Dept Cardiothorac Surg, F-13385 Marseille 05, France
关键词
D O I
10.1097/00007890-200005270-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Lung or heart-lung transplantation is a useful therapy in life-threatening pulmonary disorders during childhood. Cyclosporine A is a major immunosuppressive treatment but has a number of adverse effects including nephrotoxicity. There have been no reports on the long-term evolution of renal function in a large series of paediatric pulmonary transplantation recipients, Methods. We examined 19 patients followed up for at least 3 years after pulmonary transplantation. The mean time of follow-up was 5.36 years. Kidney function was evaluated by calculation of glomerular filtration rate (GFR) according the Schwartz formula. Results. The GFR was normal before transplantation in all patients. The short-term evolution of GFR was marked by a significant drop during the first and until the 6th month. Then, regardless of the level reached at the end of the 6th month, the GFR remained stable in all patients except one until the end of follow-up. At the end of follow-up, 31% had normal GFR, 57% had mild chronic renal failure, and 5% had advanced renal failure. Hypertension was frequent and associated with renal failure. Conclusions. Paediatric pulmonary recipients showed evidence of long-term cyclosporine A-associated nephrotoxicity. Most of this toxicity occurred during the first 6 months.
引用
收藏
页码:2055 / 2059
页数:5
相关论文
共 50 条
  • [31] NEED FOR STEROIDS IN CYCLOSPORINE-TREATED CADAVERIC RENAL-TRANSPLANT RECIPIENTS
    DEVECCHI, A
    TARANTINO, A
    RIVOLTA, E
    EGIDI, F
    PONTICELLI, C
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (05) : 999 - 999
  • [32] UNUSUAL MANIFESTATIONS OF TUBERCULOSIS IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    WONG, LL
    LEVIN, BS
    COLLINS, GM
    BRY, WI
    CLINICAL TRANSPLANTATION, 1993, 7 (01) : 18 - 24
  • [34] PREDICTORS OF GRAFT LOSS IN 197 PREGNANCIES IN CYCLOSPORINE-TREATED (CSA) FEMALE KIDNEY-TRANSPLANT RECIPIENTS
    ARMENTI, VT
    CATER, JR
    RADOMSKI, JS
    GAUGHAN, WJ
    MORITZ, MJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 993 - 993
  • [35] Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients
    Mück, W
    Mai, I
    Fritsche, L
    Ochmann, K
    Rohde, G
    Unger, S
    Johne, A
    Bauer, S
    Budde, K
    Roots, I
    Neumayer, HH
    Kuhlmann, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) : 251 - 261
  • [37] NEW ONSET OF DIABETES IN FK-506 VS CYCLOSPORINE-TREATED KIDNEY-TRANSPLANT RECIPIENTS
    SCANTLEBURY, V
    SHAPIRO, R
    FUNG, J
    TZAKIS, A
    MCCAULEY, J
    JORDAN, M
    JENSEN, C
    HAKALA, T
    SIMMONS, R
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3169 - 3170
  • [38] KIDNEY GRAFT-SURVIVAL RATES IN BLACK CYCLOSPORINE-TREATED RECIPIENTS
    OPELZ, G
    PFARR, E
    ENGELMANN, A
    KEPPEL, E
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (06) : 3918 - 3920
  • [39] TIME-COURSE OF THE DECLINE IN RENAL-FUNCTION IN CYCLOSPORINE-TREATED HEART-TRANSPLANT RECIPIENTS
    ZIETSE, R
    BALK, AH
    VANDERDORPEL, MA
    MEETER, K
    BOS, E
    WEIMAR, W
    AMERICAN JOURNAL OF NEPHROLOGY, 1994, 14 (01) : 1 - 5
  • [40] DELAYED ACUTE REJECTION EPISODES IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    MERION, RM
    GREATOREX, RA
    CALNE, RY
    ANNALS OF SURGERY, 1985, 201 (04) : 444 - 446